Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Series A Common Stock, $0.0001 par value per share
-
Shares outstanding
-
31,278,271
-
Total 13F shares
-
17,500,774
-
Share change
-
-2,168,703
-
Total reported value
-
$78,763,978
-
Put/Call ratio
-
452%
-
Price per share
-
$4.50
-
Number of holders
-
66
-
Value change
-
-$8,862,770
-
Number of buys
-
27
-
Number of sells
-
33
Institutional Holders of Sagimet Biosciences Inc. - Series A Common Stock, $0.0001 par value per share (SGMT) as of Q4 2024
As of 31 Dec 2024,
Sagimet Biosciences Inc. - Series A Common Stock, $0.0001 par value per share (SGMT) was held by
66 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,500,774 shares.
The largest 10 holders included
Point72 Asset Management, L.P., NEA Management Company, LLC, Blue Owl Capital Holdings LP, Alyeska Investment Group, L.P., VANGUARD GROUP INC, BlackRock, Inc., BAKER BROS. ADVISORS LP, Rock Springs Capital Management LP, CITADEL ADVISORS LLC, and HHLR ADVISORS, LTD..
This page lists
66
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.